Equities
Basic MaterialsChemicals
  • Price (GBX)6,826.00
  • Today's Change46.00 / 0.68%
  • Shares traded413.68k
  • 1 Year change-8.47%
  • Beta0.5479
Data delayed at least 20 minutes, as of Jul 06 2022 16:52 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Croda International PLC is a United Kingdom-based consumer care and life sciences focused company. The Company operates through two segments: Consumer Care, and Life Sciences. The Consumer Care segment is focused on high-value niches in the markets of skin care, hair care, solar protection, fabric and surface care, and fragrances. The Consumer Care comprises four businesses: beauty care, beauty actives, home care, and fragrances and flavors. The Company's Life Sciences segment comprises three businesses, including patient health, consumer and veterinary health, crop protection, and seed enhancement. It is engaged in leveraging in-house developed and acquired technologies, building scale for the delivery of customers’ drug, vaccine, and crop science products.

  • Revenue in GBP (TTM)1.89bn
  • Net income in GBP320.80m
  • Incorporated1925
  • Employees6.14k
  • Location
    Croda International PlcCowick HallGOOLE DN14 9AAUnited KingdomGBR
  • Phone+44 140 586 0551
  • Fax+44 140 586 1767
  • Websitehttps://www.croda.com/en-gb
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Orion Oyj895.48m164.34m5.29bn3.38k32.149.6126.375.911.361.367.414.550.86541.666.05310,849.5015.9018.9424.3123.8257.9259.5218.3719.891.082,397.000.1709101.61-3.44-0.613-11.87-4.8912.25-0.6537
Swedish Orphan Biovitrum AB (publ)1.34bn201.01m5.44bn1.57k26.202.7713.814.078.498.4956.5580.490.34621.334.7410,771,650.005.208.456.5010.6174.5576.4115.0321.080.66238.180.29150.001.7624.44-17.4427.3117.53--
DiaSorin SpA-85.86bn-85.86bn6.35bn3.36k--------------------------16.63--19.02--67.86--24.99------25.2440.4316.8025.4622.5825.685.59
Ipsen SA2.58bn554.85m6.50bn5.74k11.652.718.572.527.757.7535.9833.290.64362.485.76522,127.4013.879.5318.8113.4682.0681.5021.5514.051.4141.240.201122.4511.6512.4118.8223.422.817.14
Grifols SA4.24bn162.05m8.98bn23.23k63.422.1616.732.120.27690.27697.228.140.28591.3910.34212,332.401.544.232.025.1539.7844.515.3812.070.93574.500.569126.75-7.624.02-71.29-19.121.49--
Qiagen NV1.93bn450.55m9.19bn6.00k20.893.4114.634.752.272.279.7313.880.38722.566.10373,741.909.023.6910.274.2864.6565.5423.2911.681.85196.990.375--20.3910.9742.7144.8417.07--
Croda International Plc1.89bn320.80m9.47bn6.14k29.555.4021.715.012.292.2913.5212.570.59782.556.02308,003.3010.2111.1711.7513.1649.6943.7117.0816.390.9823.600.346461.7835.918.7359.1310.288.535.70
Vifor Pharma AG1.51bn126.59m9.68bn2.30k76.603.2123.836.392.252.2226.9853.780.34031.963.78762,695.605.154.776.756.3061.7059.8115.1313.941.56--0.132102.792.858.495.70-0.0681-2.520.00
BioMerieux SA2.90bn516.13m10.12bn13.08k19.473.7314.003.495.065.0628.4226.400.79032.405.68258,198.2014.029.7818.2513.1358.1655.4717.7412.691.6467.030.127214.148.279.9348.6427.404.4820.59
Eurofins Scientific SE5.77bn865.94m12.06bn57.99k14.523.028.952.095.033.7333.4924.180.750330.955.20115,838.4011.657.6614.599.7328.3123.5215.5311.801.1714.160.370616.2223.5121.5050.0739.8821.0737.97
UCB SA4.96bn905.87m13.80bn8.56k15.201.8611.652.785.435.4529.7544.330.41971.665.09674,804.407.677.399.659.3075.1174.3418.2816.731.0022.500.20228.568.046.8544.1314.2129.002.48
Data as of Jul 06 2022. Currency figures normalised to Croda International Plc's reporting currency: UK Pound GBX

Institutional shareholders

30.24%Per cent of shares held by top holders
HolderShares% Held
Mawer Investment Management Ltd.as of 31 Dec 20216.44m4.61%
RBC Global Asset Management (UK) Ltd.as of 20 Jan 20224.94m3.54%
Royal London Asset Management Ltd.as of 02 Jun 20224.57m3.27%
Massachusetts Financial Services Co.as of 17 Jun 20224.54m3.25%
BlackRock Fund Advisorsas of 02 Jun 20224.26m3.05%
Norges Bank Investment Managementas of 14 Jan 20224.19m3.00%
The Vanguard Group, Inc.as of 02 Jun 20224.15m2.97%
MFS International (UK) Ltd.as of 02 Jun 20223.77m2.70%
Impax Asset Management Ltd.as of 02 Jun 20223.15m2.26%
Legal & General Investment Management Ltd.as of 02 Jun 20222.23m1.60%
More ▼
Data from 31 Dec 2021 - 31 May 2022Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.